6 recruiting. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Recruiting 6 |
| Phase 2 | 1 | Recruiting 1 |
Follow Burns: new trials by email Literature Review of Burns trials Research Report on Burns
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients IP1 control cream (Vehicle base), IP2 - 0.5% w/w FS2 - Burn Scar, Burn Wound | Phase 2 / Phase 3 | Recruiting | Birch BioMed Inc | 70 | 2027-03-01 | 2026-09-30 |
| Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) Trial Plasma, Standard care - Burn Injury, Thermal Burn | Phase 3 | Recruiting | Jason Sperry | 750 | 2026-08-31 | 2026-09-01 |
| Effect of Early Dexamethasone on Major Complications and All-cause Mortality in Severe Burns Dexamethasone, Placebo - Severe Burns | Phase 3 | Recruiting | Nantes University Hospital | 478 | 2025-11-07 | 2025-11-18 |
| Novel Strategies for Reducing Burn Scar Itch Famotidine and 4% topical cromolyn sodium, Placebo - Burn Scar, Itch Scarring | Phase 3 | Recruiting | The University of Texas Medical Branch, Galveston | 44 | 2025-03-01 | 2026-10-05 |
| Phase III Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents denovoSkin(TM), STSG - Burns | Phase 3 | Recruiting | CUTISS AG | 70 | 2024-12-13 | 2026-08-10 |
| Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting Skin Xenotransplant, Autograft(ing) - Burns Degree Third, Burn (Disorder) | Phase 3 | Recruiting | XenoTherapeutics, Inc. | 50 | 2024-05-09 | 2025-04-02 |
Cicatrix (2) · Pruritus (1) · Wounds and Injuries (1)
Wounds and Injuries (5) · Pathological Conditions, Signs and Symptoms (3) · Fibrosis (2) · Pathologic Processes (2) · Signs and Symptoms (1) · Skin Diseases (1) · Skin Manifestations (1) · Skin and Connective Tissue Diseases (1)
Cromolyn Sodium (1) · Dexamethasone (1) · Famotidine (1) · I-kappa B Kinase (1) · Standard of Care (1)
Birch BioMed Inc (1) · CUTISS AG (1) · Jason Sperry (1) · Nantes University Hospital (1) · The University of Texas Medical Branch, Galveston (1) · XenoTherapeutics, Inc. (1)
United States (3) · France (2) · Belgium (1) · Canada (1) · Germany (1) · Italy (1) · Netherlands (1) · Poland (1) · Portugal (1) · Spain (1) · Switzerland (1)
Bounthavy Homsombath, MD (1) · Carlos Camozzi, MD, PHD (1) · Celeste Finnerty, PhD (1) · Jason Sperry, MD (1)